Genome sequences of three live attenuated vaccine strains of Brucella species and implications for pathogenesis and differential diagnosis

Journal of Bacteriology

Volumn 194, Issue 21, 2012, Pages 6012-6013

  Wang, Yufei ^a   Ke, Yuehua ^a   Wang, Zhoujia ^a   Yuan, Xitong ^a   Qiu, Yefeng ^a   Zhen, Qing ^b   Xu, Jie ^a   Li, Tiefeng ^c   Wang, Dali ^c   Huang, Liuyu ^a   Chen, Zeliang ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b JILIN UNIVERSITY   (China)

^c Chinese Base for Cotrol of Plague and Brucellosis   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BRUCELLA; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; BRUCELLA SUIS; DIFFERENTIAL DIAGNOSIS; GENE DELETION; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PATHOGENESIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; VACCINATION;

BRUCELLA ABORTUS; BRUCELLA MELITENSIS; BRUCELLA SUIS; BRUCELLA VACCINE; BRUCELLOSIS; DIAGNOSIS, DIFFERENTIAL; DNA, BACTERIAL; GENOME, BACTERIAL; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; VACCINES, ATTENUATED;

BRUCELLA; BRUCELLA MELITENSIS; BRUCELLA MELITENSIS BIOVAR ABORTUS;

EID: 84868624346     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.01483-12     Document Type: Article

References (15)

1. Alcantara RB, et al. 2004. Intact purine biosynthesis pathways are required for wild-type virulence of Brucella abortus 2308 in the BALB/c mouse model. Infect. Immun. 72:4911-4917.
2. Aziz RK, et al. 2008. The RAST server: rapid annotations using subsystems technology. BMC Genomics 9:75.
3. Blasco JM. 1997. A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats. Prev. Vet. Med. 31:275-283.
4. Boschiroli ML, et al. 2001. Brucellosis: a worldwide zoonosis. Curr. Opin. Microbiol. 4:58-64.
5. Briones G, et al. 2001. Brucella abortus cyclic beta-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells. Infect. Immun. 69:4528-4535.
6. Cloeckaert A, et al. 2004. Development and evaluation as vaccines in mice of Brucella melitensis Rev 1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis. Vaccine 22:2827-2835.
7. Grillo MJ, et al. 2006. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants. Vaccine 24:2910-2916.
8. Jimenez de Bagues et al. 1992. An ELISA with Brucella lipopolysaccharide antigen for the diagnosis of B. melitensis infection in sheep and for the evaluation of serological responses following subcutaneous or conjunctival B. melitensis strain Rev 1 vaccination. Vet. Microbiol. 30:233-241.
9. Lagesen K, et al. 2007. RNAmmer: consistent and rapid annotation of ribosomal RNA genes. Nucleic Acids Res. 35:3100 -3108.
10. Lowe TM, Eddy SR. 1997. tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence. Nucleic Acids Res. 25:955-964.
11. Moriyon I, et al. 2004. Rough vaccines in animal brucellosis: structural and genetic basis and present status. Vet. Res. 35:1-38.
12. Nicoletti P. 1990. Vaccination against Brucella. Adv. Biotechnol. Processes 13:147-168.
13. Schurig GG, Sriranganathan N, Corbel MJ. 2002. Brucellosis vaccines: past, present and future. Vet. Microbiol. 90:479-496.
14. Yang X, Thornburg T, Walters N, Pascual DW. 2010. DeltaznuADeltapurE Brucella abortus 2308 mutant as a live vaccine candidate. Vaccine 28:1069-1074.
15. Young E. 1983. Human brucellosis. Rev. Infect. Dis. 5:821- 842.